Overview The Suppression of Toll Like Receptors by Insulin Status: Unknown status Trial end date: 2013-12-01 Target enrollment: Participant gender: Summary This study will help us understand the possible beneficial effects of insulin in inflammation. Inflamamtion is considered to be the cause of atherosclerosis and heart disease. Phase: Phase 2 Details Lead Sponsor: Kaleida HealthCollaborator: American Diabetes AssociationTreatments: InsulinInsulin, Globin Zinc